These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3095298)

  • 1. Antagonistic interactions of macrolides and synergimycins on bacterial ribosomes.
    Di Giambattista M; Vannuffel P; Sunazuka T; Jacob T; Omura S; Cocito C
    J Antimicrob Chemother; 1986 Sep; 18(3):307-15. PubMed ID: 3095298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of binding of macrolides, lincosamides, and synergimycins to ribosomes.
    Di Giambattista M; Engelborghs Y; Nyssen E; Cocito C
    J Biol Chem; 1987 Jun; 262(18):8591-7. PubMed ID: 3110150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence stopped flow analysis of the interaction of virginiamycin components and erythromycin with bacterial ribosomes.
    Moureau P; Engelborghs Y; Di Giambattista M; Cocito C
    J Biol Chem; 1983 Dec; 258(23):14233-8. PubMed ID: 6417137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of leucomycins and analogues on binding [14C ]erythromycin to Escherichia coli ribosomes.
    Pestka S; Nakagawa A; Omura S
    Antimicrob Agents Chemother; 1974 Nov; 6(5):606-12. PubMed ID: 15825314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of polypeptide synthesis in cell-free systems by virginiamycin S and erythromycin. Evidence for a common mode of action of type B synergimycins and 14-membered macrolides.
    Chinali G; Nyssen E; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1988 Jan; 949(1):71-8. PubMed ID: 3120788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the reversible binding of virginiamycin M to ribosome and particle functions after removal of the antibiotic.
    Nyssen E; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1989 Sep; 1009(1):39-46. PubMed ID: 2506929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin.
    Poulsen SM; Kofoed C; Vester B
    J Mol Biol; 2000 Dec; 304(3):471-81. PubMed ID: 11090288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis of the inhibitory activities of type A and type B synergimycins and related antibiotics on ribosomes.
    Di Giambattista M; Chinali G; Cocito C
    J Antimicrob Chemother; 1989 Oct; 24(4):485-507. PubMed ID: 2515187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electronic and lipophilic interactions of macrolides (leucomycin derivatives) with ribosomal receptor sites.
    Mager PP
    Acta Histochem; 1980; 66(1):40-3. PubMed ID: 6776777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competition between erythromycin and virginiamycin for in vitro binding to the large ribosomal subunit.
    Parfait R; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1981 Jul; 654(2):236-41. PubMed ID: 6793070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of action of virginiamycin-like antibiotics (synergimycins) on protein synthesis in bacterial cell-free systems.
    Cocito C; Chinali G
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():35-52. PubMed ID: 3932310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel dimeric derivatives of leucomycins and tylosin, sixteen-membered macrolides.
    Omura S; Miyano K; Matsubara H; Nakagawa A
    J Med Chem; 1982 Mar; 25(3):271-5. PubMed ID: 7040661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reaction of some macrolide antibiotics with the ribosome. Labeling of the binding site components.
    Tejedor F; Ballesta JP
    Biochemistry; 1986 Nov; 25(23):7725-31. PubMed ID: 3542032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of novel macrolide structures to macrolides-lincosamides-streptogramin B-resistant ribosomes inhibits protein synthesis and bacterial growth.
    Goldman RC; Kadam SK
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1058-66. PubMed ID: 2506804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of ions and pH on the binding of virginiamycin S to ribosomes.
    Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1983 May; 757(1):92-100. PubMed ID: 6404307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic studies on the interaction between a ribosomal complex active in peptide bond formation and the macrolide antibiotics tylosin and erythromycin.
    Dinos GP; Kalpaxis DL
    Biochemistry; 2000 Sep; 39(38):11621-8. PubMed ID: 10995229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of 3-O-acetyl-4"-O-isovaleryltylosin to ribosomes from a macrolide-resistant strain of Staphylococcus aureus.
    Tsuchiya M; Sawa T; Takeuchi T; Umezawa H; Okamoto R
    J Antibiot (Tokyo); 1982 Jun; 35(6):673-9. PubMed ID: 7118723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical probing of a virginiamycin M-promoted conformational change of the peptidyl-transferase domain.
    Vannuffel P; Di Giambattista M; Cocito C
    Nucleic Acids Res; 1994 Oct; 22(21):4449-53. PubMed ID: 7971275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lasting damage to bacterial ribosomes by reversibly bound virginiamycin M.
    Parfait R; Cocito C
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5492-6. PubMed ID: 6776538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A spectrofluorimetric study of the interaction between virginiamycin S and bacterial ribosomes.
    Parfait R; de Béthune MP; Cocito C
    Mol Gen Genet; 1978 Oct; 166(1):45-51. PubMed ID: 105239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.